Acumen Pharmaceuticals Inc (ABOS) Stock Price

2.53 ▼ -0.23 (-8.33%)
Open: 2.64 Vol: 201 Day's range: 2.50 - 2.67 Apr 07, 10:24 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ABOS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.52▼ 2.60▼ 2.65▼ 2.57▼ 2.68▼
MA10 2.53▼ 2.66▼ 2.68▼ 2.51▼ 2.73▼
MA20 2.60▼ 2.68▼ 2.66▼ 2.80▼ 2.39▲
MA50 2.67▼ 2.60▼ 2.49▲ 2.76▼ 1.82▲
MA100 2.69▼ 2.50▲ 2.65▼ 2.34▲ 2.01▲
MA200 2.67▼ 2.71▼ 2.92▼ 1.95▲ 3.47▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.006▼ -0.032▼ -0.024▼ -0.028▼ -0.019▼
RSI 31.070▼ 36.131▼ 41.787▼ 43.751▼ 53.196▲
STOCH 24.009     41.132     40.670     50.360     51.266    
WILL %R -97.059▼ -98.077▼ -98.333▼ -63.187     -56.736    
CCI -102.574▼ -174.680▼ -243.597▼ -21.198     11.594    
Latest Filters Detected On ABOS
RSI $ABOS RSI(14) Crossed Below 50 Set Alert
MA $ABOS Price Crossed Below MA(50) Set Alert
MA $ABOS Price Crossed Below MA(13) Set Alert
▼ GAP $ABOS Open Gap Down %3 Set Alert
▼ GAP $ABOS Open Gap Down %2 Set Alert
CDL $ABOS Evening Star Candlestick Pattern Detected Set Alert
Acumen Pharmaceuticals Inc News
Acumen targets ALTITUDE-AD Phase II readout in late 2026 while advancing EBD program with $36M funding
Thursday, March 26, 2026 03:26 PM
The current quarter featured the announcement of a $35.75 million private placement to support EBD program development and a clear target for an IND filing in mid-2027.
Acumen targets ALTITUDE-AD Phase II readout in late 2026 while advancing EBD program with $36M funding
Thursday, March 26, 2026 03:26 PM
The current quarter featured the announcement of a $35.75 million private placement to support EBD program development and a clear target for an IND filing in mid-2027.
Acumen Pharmaceuticals Q4 Earnings Call Highlights
Thursday, March 26, 2026 08:02 AM
Acumen Pharmaceuticals (NASDAQ:ABOS) outlined progress across its lead Alzheimer’s disease program and an emerging “enhanced brain delivery” (EBD) platform during its fourth-quarter and full-year 2025 ...
ABOS historical stock data
date open high low close volume
07/04/26 2.64 2.67 2.50 2.505 177,728
06/04/26 2.72 2.81 2.67 2.76 544,255
02/04/26 2.49 2.745 2.49 2.70 635,426
01/04/26 2.38 2.63 2.38 2.55 764,106
31/03/26 2.19 2.42 2.19 2.36 405,232
30/03/26 2.28 2.32 2.17 2.19 446,436
27/03/26 2.48 2.55 2.25 2.26 919,004
26/03/26 2.56 2.75 2.3587 2.55 725,026
25/03/26 2.66 2.78 2.605 2.63 424,254
24/03/26 2.68 2.68 2.52 2.59 644,094
Quote Details
52wk Low:0.855
52wk High:3.60
Vol:201
Avg Vol(3m):9.3M
1Y Chng:+145.59%
1M Chng:-9.24%
Add to Watch List
More Information
Index US Composite
Market Cap. 194.97M